Bruno Mars Scores 5th No. 1 Single on Billboard's "Hot

New Post Public Reply Private Reply Replies (0) Message Board
testuser
Bruno Mars Scores 5th No. 1 Single on Billboard's "Hot 100"; "When I Was Your Man" Marks Second Consecutive Single From RIAA Platinum Certified "UNORTHODOX JUKEBOX" to Rise to the Top Spot; Mars Makes History as Top Male Solo Artist With Most No. 1s on the "Mainstream Top 40" Airplay Chart; Grammy Award-Winning Artist to Open 2013 Billboard Music Awards With Live Performance From Las Vegas on May 19th; Sold-Out Worldwide Arena Tour Kicks Off in June

NEW YORK, NY--(Marketwired - Apr 10, 2013) - "When I Was Your Man" -- the latest hit single from Atlantic recording artist Bruno Mars' new album, "UNORTHODOX JUKEBOX" -- has ascended to the #1 spot on Billboard 's "Hot 100." The single's chart-topping success comes hot on the heels of the album's sensational first single, "Locked Out Of Heaven," which held the #1 position for six consecutive weeks earlier this year. "When I Was Your Man," which marks Mars' fifth single to reach No. 1 on the "Hot 100," has exceeded sales of 2 million stateside and 1 million overseas.

Mars will celebrate by opening the upcoming 2013 Billboard Music Awards with an eagerly anticipated live performance. The awards are set to air live from the MGM Grand Garden Arena in Las Vegas on Sunday, May 19 th (8:00-11:00 p.m., ET) on The ABC Television Network (check local listings). In addition, Bruno is among the nominees for the event's Milestone Award. Fans are invited to vote for the Chevrolet-sponsored honors now at www.billboard.com/milestone/vote .

Furthermore, "When I Was Your Man" represents Mars' sixth #1 single on Billboard 's "Mainstream Top 40" radio airplay chart, pushing him above Justin Timberlake and Nelly as the solo male artist with the most chart-toppers in the tally's 20-year history. According to Billboard magazine, Mars has racked his first five Hot 100 No. 1s faster than any male since Elvis Presley. As if that weren't enough, "When I Was Your Man" stands as Mars' 11 th song to pass 1 million downloads -- all since his arrival on the scene just three short years ago. The GRAMMY®-winning superstar can now lay claim to a truly remarkable statistic, marking over 100 million singles sold worldwide in his role as both solo artist and as chart-topping writer/producer/featured performer.

Currently starring on the April cover of GQ , Mars offered a rendition of "When I Was Your Man" on a recent installment of the nationally syndicated Ellen DeGeneres Show . The performance can be viewed now at www.brunomars.com/news/when-i-was-your-man-performance-ellen-2354106 .

"UNORTHODOX JUKEBOX" has quickly proven a worldwide phenomenon. The album -- which recently hit the top spot on the Billboard 200 , marking the GRAMMY®-winning Mars' first #1 album in the U.S. -- has been certified platinum by the RIAA, commemorating domestic sales in excess of 1 million. "UNORTHODOX JUKEBOX" has also received platinum certifications in Australia, New Zealand, Canada, France, Ireland and the United Kingdom, where it exploded to the top spot on the album charts upon its initial release, making history as Britain's fastest selling solo album of 2012. The extraordinary accomplishment of "UNORTHODOX JUKEBOX" follows the equivalent popularity of Mars' now classic 2010 debut, "DOO-WOPS & HOOLIGANS," which also entered the charts at #1 and soon proved the UK's third best-selling album of 2011.

Mars is currently poised to embark on his epic "Moonshine Jungle Tour," kicking off Saturday, June 22 nd at Washington, DC's Verizon Center before traveling the planet though November. Several dates of the worldwide arena tour in both North America and Europe sold out within minutes of their announcement, including shows in New York, London, Paris, Dublin and Madrid, as well as two night stands at Los Angeles' Staples Center and Denver's Red Rocks Amphitheatre. For up-to-the-minute tour information, please see www.brunomars.com/moonshinejungletour .

For additional news and information, please visit: www.brunomars.com , www.facebook.com/thatbrunomars , www.youtube.com/brunomars , and twitter.com/BRUNOMARS .

Contact: Cara Donatto National cara.donatto@atlanticrecords.com 818.238.6819 Ashley Kalmanowitz Tour/Online ashley.kalmanowitz@atlanticrecords.com 212.707.2051

Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classic vs. Youngtimer Cars: Evolution in Collecting

Updated Category News Views 90

The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...

Continue Reading
Smart Banner Choices: Decisions Beyond Design

Updated Category News Views 152

Location, Location, Location: Banner Insights Picking a banner isn't just a quick snap decision. You got to think big, and location is a starting line. Adam Norsworthy from Minuteman Press underscores that understanding how and where this piece of publicity will hang matters more than you might guess. Outdoor or indoor isn't just a weather question; it's a matter of...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 80

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 37

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Updated Category News Views 146

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Continue Reading
Nagarro's Earnings Show Stagnant Growth Amid Flat Margins

Updated Category News Views 96

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

Continue Reading
APEC Summit 2026: Shenzhen in the Spotlight

Updated Category News Views 58

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Continue Reading
Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 72

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 76

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 58

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading

Top 5 Most Recently Viewed Articles

Diane Nussbaum Celebrated as Pinnacle Professional Leader

Updated Category News Views 241

Diane Nussbaum Recognized for Excellence in Culinary Arts The Inner Circle proudly acknowledges Diane Nussbaum as a distinguished member in the ranks of Pinnacle Professionals. Her recent recognition underscores her invaluable contributions to the culinary world, especially in pastry arts and community engagement. Celebrating Achievements in Pastry Diane Nussbaum's career...

Continue Reading
Innovative Immunotherapy Approach Targeting Gastric Cancer Unveiled

Updated Category News Views 64

New Insights into Immunotherapy for Gastric Cancer ImmPACT Bio, a pioneering clinical-stage biopharmaceutical company, is making significant strides in cancer treatment with its innovative IMPT-601 therapy. This groundbreaking approach focuses on Claudin18.2 and TGF-? bispecific CAR T-cell therapy, aiming to redefine how we tackle gastric cancer. Understanding IMPT-601...

Continue Reading
ASML Holding's P/E Ratio Analysis: Understanding its Value

Updated Category News Views 322

Insights into ASML Holding's P/E Ratio In today's market, the share price of ASML Holding Inc. (NASDAQ: ASML) stands at $987.03, reflecting a rise of 2.12%. Although the stock experienced a decline of 6.22% over the last month, it has seen a significant surge of 46.89% over the past year. Investors might wonder about the stock's valuation, especially in light of the...

Continue Reading
Recent Insider Sales Raise Questions for Tetra Tech Stakeholders

Updated Category News Views 67

Recent Insider Activity at Tetra Tech Kirsten M Volpi, a notable Board Member at Tetra Tech (NASDAQ: TTEK), recently made headlines with an insider sale. She sold 1,950 shares, which totaled around $89,700. This transaction was reported in a Form 4 filing with the SEC, sparking interest among investors keen on such activities. Understanding Insider Transactions Insider...

Continue Reading
Cabaletta Bio's Short Interest Surge: What Investors Need to Know

Updated Category News Views 112

Understanding Cabaletta Bio's Recent Short Interest Trends Cabaletta Bio has seen a noticeable increase in its short percent of float, rising by a significant 38.24% since the previous report. Currently, the company has reported that there are a staggering 6.22 million shares sold short, which represents about 13.16% of all regular shares available for trading. This high...

Continue Reading